CAP GO
DEAD

Serial Number

79197165

Owner

CEVEC Pharmaceuticals GmbH

Attorney

Miriam D. Trudell

Filing Date

Jul 11, 2016

Add to watchlist:

No watchlists yet
View on USPTO

CAP GO Trademark

Serial Number: 79197165 • Registration: 5343212

CAP GO is a trademark filed by CEVEC Pharmaceuticals GmbH on July 11, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

CEVEC Pharmaceuticals GmbH (7 trademarks)

Gottfried-Hagen-Strasse 62
51105 Köln , DE

Entity Type: 03

Trademark Details

Filing Date

July 11, 2016

Registration Date

November 28, 2017

Published for Opposition

September 12, 2017

Cancellation Date

June 14, 2024

Goods & Services

Medicines for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except thyreostatics and cough and cold preparations; pharmaceutical and veterinary products, preparations and reagents for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, all afore mentioned goods except thyreostatics and cough and cold preparations; chemical, biological and biochemical preparations for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, preparations and reagents for medical and veterinary purposes for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except cough and cold preparations, except chromatography chemicals and media, and except chemicals for use in separation and purification; diagnostic and analytical preparations for medical and veterinary purposes for the treatment and prevention of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases; cultures of micro-organisms, protein arrays, synthetic polypeptides, nucleotide arrays, nucleic acid sequence, eukaryotic cell lines and eukaryotic cells for medical, veterinary and diagnostic purposes, except cough and cold preparations

Chemical, biological and biochemical products, preparations and reagents for scientific, research, laboratory, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical products, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; micro-organisms, proteins, polypeptides, nucleotides, nucleic acids, eukaryotic cell lines and eukaryotic cells for scientific, research, laboratory, industrial and commercial purposes; all other than for medical or veterinary use

Scientific and industrial research, in particular in the fields of medicine, pharmacy, molecular biology, biotechnology and genetics; research and development of drugs, diagnostic and analytical preparations, therapy procedures and expression systems; scientific, technical and industrial consultancy, in particular in the field of research medicine, pharmacy, molecular biology, biotechnology and genetics; scientific and industrial research and development of eukaryotic cell lines, eukaryotic cells, micro-organisms, polypeptides, proteins, nucleotides, nucleic acids, for third parties for scientific, research, laboratory development, industrial and commercial purposes, in particular for use in the field of medicine, pharmacy, molecular biology, biotechnology and genetics, except services relating to capture and intermediate purification of proteins

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
May 16, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 28, 2025 INTS
INVALIDATION PROCESSED
Apr 28, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 14, 2025 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2024 NREP
CANCELLED SECTION 71
Jun 14, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 19, 2023 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 21, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 21, 2023 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 21, 2023 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 21, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 21, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 21, 2023 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 28, 2022 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 13, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 13, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 13, 2021 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 11, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 11, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 11, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 11, 2021 REAP
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 22, 2018 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 19, 2018 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Aug 23, 2018 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 22, 2018 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 17, 2018 TCCA
TEAS SECTION 7 REQUEST RECEIVED
Jul 27, 2018 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 27, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 7, 2018 FICS
FINAL DISPOSITION PROCESSED
Mar 7, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 28, 2017 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2017 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 12, 2017 NPUB
PUBLISHED FOR OPPOSITION
Sep 12, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 23, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2017 TROA
REFUSAL PROCESSED BY IB
Dec 24, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 8, 2016 RFCS
REFUSAL PROCESSED BY MPU
Dec 8, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 8, 2016 RFCR
NON-FINAL ACTION WRITTEN
Dec 7, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 6, 2016 MAFR
ASSIGNED TO EXAMINER
Dec 2, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 1, 2016 REPR